Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) functions as a high-specificity epitope tag for protein purification and detection in molecular biology (product source). The peptide exhibits high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) and purity (>98% by HPLC/MS) for robust experimental reproducibility. Its competitive binding to Anti-HA antibodies enables efficient elution of HA-tagged fusion proteins during immunoprecipitation assays [internal review]. The HA peptide is essential in studies dissecting protein-protein interactions, ubiquitination, and complex cellular signaling, as evidenced in translational cancer research (Dong et al., 2025). Proper storage (desiccated, -20°C) and avoidance of long-term solution storage are required to maintain performance.

Biological Rationale

The HA tag peptide is derived from the human influenza hemagglutinin protein, a surface glycoprotein critical for viral entry into host cells (Dong et al., 2025). The nine-amino acid epitope (YPYDVPDYA) is recognized with high specificity by commercially available Anti-HA antibodies. This makes the HA peptide an ideal molecular tag for fusion proteins in heterologous systems. The small size of the tag minimizes interference with native protein folding, localization, or function [internal review]. Its use standardizes immunoprecipitation, detection, and purification protocols across a variety of research contexts, including cancer signaling and ubiquitination studies.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide acts as a competitive ligand for Anti-HA antibodies. When introduced into immunoprecipitation workflows, the HA peptide binds to the paratope of the antibody, displacing HA-tagged fusion proteins from the antibody-bead complex (product technical notes). This facilitates gentle, specific elution of target proteins. The mechanism enables downstream analysis of protein complexes, interaction partners, and post-translational modifications without harsh chemical conditions. The peptide’s high affinity and specificity ensure minimal cross-reactivity and background. Its sequence is orthogonal to endogenous mammalian proteins, reducing non-specific binding [internal: advanced strategies]. The HA tag system is compatible with western blotting, immunofluorescence, and mass spectrometry workflows.

Evidence & Benchmarks

• HA-tagged fusion proteins are efficiently detected and purified using the synthetic HA peptide and Anti-HA antibodies in cell lysates and tissue extracts (A6004 product page).
• The HA peptide’s high purity (>98%) and solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) support reproducible results across buffer systems (A6004 specs).
• Competitive elution with the HA peptide preserves the integrity of protein complexes, enabling studies on protein-protein interactions and post-translational modifications [internal: workflow comparison].
• In translational cancer research, HA tag-based immunoprecipitation has been used to dissect ubiquitination pathways, such as the NEDD4L-PRMT5 axis in colorectal cancer metastasis (Dong et al., 2025).
• Benchmark studies report that the HA peptide does not elute non-HA-tagged proteins or cause significant background signal [internal: specificity review].

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is broadly used in:

• Affinity purification of HA-tagged fusion proteins from cellular extracts.
• Competitive elution in immunoprecipitation workflows using Anti-HA Magnetic Beads or conventional antibodies.
• Detection of tagged proteins by western blot, immunofluorescence, and ELISA.
• Mapping protein-protein interactions, ubiquitination, and signaling pathway components, especially in cancer and cell signaling research (Dong et al., 2025).

Recent advances integrate the HA tag in complex disease models, such as investigating how E3 ligases regulate protein networks in metastatic colorectal cancer [internal: translational focus]. This article clarifies how the A6004 peptide translates these findings into reproducible laboratory workflows, building on the mechanistic insights detailed in previous internal articles.

Common Pitfalls or Misconceptions

• The HA tag peptide cannot purify native, untagged proteins—it only works with proteins genetically fused to the HA epitope.
• Excessive peptide concentrations do not necessarily improve elution efficiency and may increase background.
• Long-term storage of peptide solutions at room temperature or 4°C leads to degradation; always store desiccated at -20°C.
• The HA peptide is not suitable for in vivo tracking of proteins in live animals due to immunogenicity and lack of cell permeability.
• Cross-reactivity is minimal in mammalian systems, but rare endogenous sequences or overexpression artifacts may occasionally yield weak background.

Workflow Integration & Parameters

The HA peptide (A6004) is supplied as a lyophilized powder with confirmed purity and identity by HPLC and mass spectrometry. Reconstitute the peptide in water, DMSO, or ethanol to the desired concentration, keeping within solubility limits (≥46.2 mg/mL in water, ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol). For immunoprecipitation elution, typical working concentrations range from 0.1 to 1 mg/mL, depending on assay sensitivity and volume. Store all stock solutions at -20°C and avoid repeated freeze-thaw cycles. Integrate HA peptide elution steps following antibody capture to maximize specific recovery of HA-tagged proteins, as outlined in the A6004 product documentation (A6004 protocol). For advanced integration scenarios, see this strategy-focused article, which explores the peptide's role in dissecting cancer signaling, extending the practical advice provided here.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a cornerstone of molecular biology research, enabling sensitive, specific, and reproducible detection and purification of HA-tagged proteins. Its robust physical properties and orthogonal specificity make it indispensable for dissecting protein interactions and regulatory networks, as demonstrated in advanced cancer signaling studies involving the NEDD4L-PRMT5 axis (Dong et al., 2025). Ongoing improvements in peptide synthesis and antibody engineering will further expand the utility of the HA tag system in complex biological models. For researchers seeking a validated, high-purity tag for protein workflow integration, the Influenza Hemagglutinin (HA) Peptide (A6004) offers a proven solution.